BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3993832)

  • 21. Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors.
    Yamamoto S; Tsuda H; Takano M; Kita T; Kudoh K; Furuya K; Tamai S; Matsubara O
    Mod Pathol; 2008 Feb; 21(2):115-24. PubMed ID: 18084257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystadenofibromas of the ovary with epithelial atypia.
    Kao GF; Norris HJ
    Am J Surg Pathol; 1978 Dec; 2(4):357-63. PubMed ID: 736210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrioid ciliated-cell tumors of the ovary: a report of five cases.
    Eichhorn JH; Scully RE
    Int J Gynecol Pathol; 1996 Jul; 15(3):248-56. PubMed ID: 8811387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report.
    Vasilakaki T; Skafida E; Arkoumani E; Grammatoglou X; Firfiris N; Manoloudaki K
    Eur J Gynaecol Oncol; 2012; 33(2):230-2. PubMed ID: 22611972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benign endometrioid tumours of the ovary and the Müllerian concept of ovarian epithelial tumours.
    Hughesdon PE
    Histopathology; 1984 Nov; 8(6):977-90. PubMed ID: 6526392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
    Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
    Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical proliferative endometrioid tumor of ovary: Report of a rare case.
    Jetley S; Khetrapal S; Ahmad A; Jairajpuri ZS
    J Postgrad Med; 2016; 62(2):129-32. PubMed ID: 26497398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma.
    Roth LM; Langley FA; Fox H; Wheeler JE; Czernobilsky B
    Cancer; 1984 Mar; 53(5):1156-63. PubMed ID: 6692303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preservation of fertility after partial resection of bilateral ovarian cystadenofibromas: a case report.
    Ewing TL; Suh-Burgmann B
    J Reprod Med; 2011; 56(7-8):364-5. PubMed ID: 21838171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrioid adenofibroma arising in an endometriotic cyst.
    Jain D; Siraj F; Aggarwal N
    J Obstet Gynaecol; 2011 May; 31(4):352-4. PubMed ID: 21534769
    [No Abstract]   [Full Text] [Related]  

  • 31. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
    Shi H; Chen X; Lv B; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferating endometrioid cystadenofibroma of the ovary. Report of a case in a teenager.
    Nasca D
    Diagn Gynecol Obstet; 1982; 4(4):317-24. PubMed ID: 7166119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian atypical endometriosis: its close association with malignant epithelial tumours.
    Fukunaga M; Nomura K; Ishikawa E; Ushigome S
    Histopathology; 1997 Mar; 30(3):249-55. PubMed ID: 9088954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases.
    Bell DA; Scully RE
    Hum Pathol; 1990 Apr; 21(4):397-403. PubMed ID: 2318481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoplastic and pre-neoplastic changes in gastrointestinal endometriosis: a study of 17 cases.
    Yantiss RK; Clement PB; Young RH
    Am J Surg Pathol; 2000 Apr; 24(4):513-24. PubMed ID: 10757398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Ovarian Clear Cell Adenofibroma of Borderline Malignancy.
    Cakir E; Aydin E; Durmus NI; Samdanci E; Sahin N; Nurkabul Z
    Oman Med J; 2012 Jan; 27(1):e031. PubMed ID: 28861185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serous adenofibroma of ovary: An eccentric presentation.
    Shukla S; Srivastava D; Acharya S; Dhote S; Vagha S
    J Cancer Res Ther; 2015; 11(4):1030. PubMed ID: 26881611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian endometrioid carcinoma with an adenofibromatous pattern.
    Piura B; Goldstein J; Yanai I
    Int J Tissue React; 1986; 8(3):249-54. PubMed ID: 3781765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.